Posts Tagged ‘Wsj’
-
Tuesday, May 18th, 2010 at 07:31 | Comments Off
News Hub: Reach for the Steak, Skip the DogCategories: Wall Street Journal -
Thursday, May 13th, 2010 at 09:27 | Comments Off
New Defibrillator Avoids Wires in HeartCategories: Wall Street Journal, health -
Tuesday, May 4th, 2010 at 11:36 | Comments Off
How Not to Give a ComplimentCategories: Wall Street Journal -
Thursday, April 1st, 2010 at 02:09 | Comments Off
‘Gold Rush Is Over’ for Simple Gene DiscoveriesCategories: Wall Street Journal
A federal judge’s ruling earlier this week that some patents on human genes are invalid because they were related to isolated DNA “found in nature” is being watched closely by other holders of such patents of human genes. (Read more from the WSJ about the case.)
The genes in dispute involve BRCA1 and BRCA2, two genes that many geneticists say are particularly important because they are such powerful markers for diagnosing risk of a hereditary form of breast cancer.
But how many ..read more
-
Tuesday, March 23rd, 2010 at 08:55 | Comments Off
Testing AcupunctureCategories: Wall Street Journal, health -
Thursday, March 11th, 2010 at 03:47 | Comments Off
Not ‘War and Peace’ But Orphan-Drug Applications Are FewCategories: Wall Street Journal
The Orphan Drug Act has been around since 1983 offering tax incentives and competition protection for drugs aimed at treating rare diseases. But there have been relatively few orphan drugs developed, so the FDA is beating the bushes for more participation.
FDA staffers recently ran a two-day workshop in Claremont, Calif., to help drug developers fill out the application to get orphan-drug status, the WSJ says in an article this morning. Another workshop is planned for the University of Minnesota in ..read more
-
Wednesday, March 3rd, 2010 at 06:02 | Comments Off
Digits: Beep! Time to Take Your MedicineCategories: Wall Street Journal -
Saturday, February 20th, 2010 at 04:31 | Comments Off
The Insurance-Premium Kettle That Keeps Getting HotterCategories: Wall Street Journal, insurance
And speaking of the health-overhaul proposals (see previous post), we note an armful of stories today dealing with what has become a third-rail issue — the rates at which premiums are going up for individual health plans.
The cost of health policies has been an eye-of-the-beholder issue for a long time in the overhaul debate. There’s been broad agreement that individual rates are headed up, but overhaul opponents have contended they would rise even more under Democratic-backed health-system changes, while the ..read more
-
Wednesday, February 17th, 2010 at 05:31 | Comments Off
A Doctor’s Problem With Electronic RecordsCategories: Wall Street Journal
Paper medical records can easily go missing, contain bad or missing information and undermine patient care. But consider the alternative, says Alexander Friedman, a fellow in maternal-fetal medicine at the University of Pennsylvania.
As a resident fresh out of medical school, Friedman was working an an ememrgency room switching over to electronic medical records, he writes in a guest column on WSJ.com. Checking boxes and inserting codes required by the new system became the focus rather than ..read more
-
Saturday, February 13th, 2010 at 01:03 | Comments Off
Wanted: Ex-Congressman. Must Love Drugs. Good PayCategories: Wall Street Journal
Billy Tauzin — the former Louisiana congressman who stuck with the homespun phrases even as he pulled down $2 million a year to represent the drug industry in DC — is stepping down as the head of PhRMA, the big trade group.
The WSJ notes that he was criticized “for his support of the White House’s now-teetering plan to overhaul health care.”
Exhibit A is the letter John Boehner, the House Republican leader, sent last year to Tauzin, to complain ..read more






